May 7 Bell Works, Holmdel

Future Forum

Future Forum

HealthTech + Innovation +
STEM Awards

About

The Future Forum on Tuesday, May 7th,  highlights innovations which will transform the future. The morning will focus on HealthTech advances and the afternoon will focus on novel technologies at the Innovation Forecast.

HEALTHTECH: With advances in technology, we stand at an unprecedented time for transition and opportunity in healthcare. Providers and healthcare organizations are leveraging big data, health information exchanges, genomics, mHealth, and other transformative technologies to advance care, improve clinical outcomes, and enhance the patient experience.

Join a diverse group of practitioners, tech executives, investors/payors, entrepreneurs, and industry leaders in identifying the opportunities and challenges related to healthcare technology.

INNOVATION FORECAST: Highlights innovation throughout the region from small to large companies. This year’s program will focus on Artificial Intelligence. There will also be chats, panels and a reception after the event.
Corporate innovators, researchers, entrepreneurs, developers, advisors and students normally attend.

STEM AWARDS: A reception recognizing and celebrating our finest young leaders, we will be honoring the 2019 STEM Leaders:  Innovators to Watch, a group of up to 50 impressive young over achievers. Nominations are closed.

The fun reception taking place on the Bell Works rooftop deck, will feature music, hors d’oeuvres and theatrics.

 

PARKING:

There will be signage that follows to the conference center where you can park right in front of the entrance. If the lot is full, you can continue to the next parking lot. You will find signage like the one below with our NJTC logo that directs you:

Schedule

 
 11:00 AM

HealthTech Conference

10:30 - 11:00 am: Registration
11:00 - 11:30 am: Welcome
James Barrood, President and CEO, NJ Tech Council
Keynote: Joseph Scott, RWJBarnabas
11:30 - 12:10 am: Technology Panel
Alastair Binnie, BMS
Judy Comitto, Trinitas Medical Center
Chris Sullens, CentralReach
Jack Quigley, Horizon BCBS
Gary Rosenblum, Oticon
12:10 - 12:45 pm: Innovation Panel
Robert Zambon, Janssen
Colleen Riley, Stryker
Tiffany McLaud, Bayer
Cathy Bennett, NJHA
Michael Kirchhoff, Cooper Health
12:45 - 1:45 pm: Lunch/Networking

 2:15 PM

Innovation Forecast - Artificial Intelligence

1:30 pm: Registration
2:15 pm: Welcome: James Barrood, NJ Tech Council
2:20 pm: Keynote: Chris White, Nokia Bell Labs
2:50 pm: AI Perspectives
Kurt Bettenhausen, Siemens Corporation
Ibrahim Mohamed, Google
Merwan Mereby, Panasonic
Dan Tinkoff, McKinsey
Sanjay Macwan, Vonage
3:35 pm: Break
4:00 pm: The Challenges Ahead
Steve LeVine, Axios Future Editor
Chris Pfaff, Tech/Media LLC
KP Subbalakshmi, Stevens Institute
Anastassia Loukina, ETS
Brian McLaughlin, Rutgers
4:45 pm: Funding and Accelerating Innovation
David Sorin, McCarter & English
Tim Rollender, NJEDA
Jim Gunton, Tech Council Ventures
Eamon Gallagher, Univ City Science Ctr
Dan Borok, Newark Venture Partners
5:30 pm: Networking

 6:00 PM

STEM Awards Reception

Honoring the 2019 Innovators to Watch, the state’s rising STEM leaders. Food + Music + Theatrics + GOT Fun on the Rooftop Deck

Speakers

Joseph Scott

Executive Vice President, Health Care Transformation, RWJBarnabas Health

As the Executive Vice President for Health Care Transformation for RWJBarnabas, Mr. Scott leads strategic planning and implementation, business development, innovation and population health for the system. He joined Barnabas Health in 2014 after a successful merger between Liberty Health and the Barnabas system. In 2016 he continued serving as the President and CEO at Jersey City Medical Center while beginning work at the system level to formalize the strategic planning process. Mr. Scott served as the President and CEO of Jersey City Medical Center from 2008 until 2018 and holds board certification in healthcare management as a Fellow of the American College of Healthcare Executives (FACHE). Under his visionary leadership, Jersey City Medical Center received more than 35 awards and recognition for quality services, patient safety, and community outreach that include the Joint Commission Top Hospital Performer Award, the American Nurses Credentialing Center’s Magnet Award for Nursing Excellence designation in 2008 and re-designation in 2014 and 2018. In 2015, Jersey City Medical Center earned the prestigious Vision of Performance Excellence Award, the state-level Malcolm Baldrige Award. The Medical Center’s EMS became the first triply- accredited Emergency Medical Services in the United States. The Independent Leapfrog Group awarded Jersey City Medical Center an “A” rating in Hospital Safety and Quality for twelve consecutive rating periods (2012-2017). In 2017, Jersey City Medical Center was named a Top Teaching Hospital by the Leapfrog group. Beginning in 2014, and every year since, the hospital has received national LGBTQ HEI certification, demonstrating commitment to the diversity of the workforce, the community and healthcare equality. The organization was presented with the National Diversity in Leadership Award by the American Hospital Association. Mr. Scott is committed to making a difference in his local community as well as the future of health care and has served as Chairman of the Board of the Hudson County Chamber of Commerce and past Chair of Hospital Alliance of New Jersey, Inc. As an active leader in his community he volunteers his time and has assumed several leadership positions with community organizations including the March of Dimes, the American Heart Association, and Susan G. Komen Race for the Cure and serves as a Board Member of Big Brothers/Big Sisters of Essex, Union and Hudson Counties. The Governor appointed Joe to the Board of Trustees for New Jersey City University. On a national level, Mr. Scott is Chairman of the Board of America’s Essential Hospitals and is past Chairman of the America’s Essential Hospitals Policy Committee.

Christopher White

AAAID Research, Bell Labs

Chris leads the Algorithms, Analytics, Augmented Intelligence and Devices (AAAID) research lab in Bell Labs. He joined Bell Labs in 1997 after graduating with a Ph.D. in theoretical quantum chemistry from the University of California in Berkeley, California. His research interests include the development of computational models and methods for the simulation and control of interesting physical and digital systems. This has included work in areas ranging from linear scaling quantum chemistry simulations, to the design of new optical devices, to the global control of transparent optical mesh networks and to understanding and facilitating the propagation of ideas in organizations. In addition to the management of an international team of world-class researchers, Dr. White’s current work focuses on the creation of assisted thinking tools that leverage structural similarity in data with the goal of augmenting human intelligence.

Alastair Binnie

Head of Information Technology for Research & Development, Bristol-Myers Squibb

Alastair Binnie is Head of Information Technology for Research & Development at Bristol-Myers Squibb. In this role he is accountable for planning and delivering all aspects of IT’s value proposition to BMS R&D, which includes digital platforms supporting discovery, preclinical, translational medicine, clinical development, regulatory sciences, pharmacovigilance, and medical affairs. His mission is to enable R&D by providing the right tools and the right data, to the right scientists, at the right time. He joined BMS in 1999 as the leader of the Discovery Automation team in Wallingford, Connecticut, and progressed through a range of leadership roles in research technology and IT, assuming his current role in 2015. From 1994-99 he led the Discovery Technologies group at Glaxo Wellcome R&D in the UK. Prior to joining the pharmaceutical industry, Alastair worked as a design engineer in the space industry, developing instrumentation for microgravity research for the European Space Agency. He is a current or recent Board member of global life-science technology industry groups, including PRISME, the Society of Laboratory Automation and Screening, and the Pistoia Innovation Alliance. He represents BMS on the New Jersey Technology Council. Alastair grew up in Scotland. He has degrees in mechanical engineering, design engineering and industrial design from Brunel University, Imperial College of Science and Technology, and the Royal College of Art. He now lives in Princeton with his wife Zoe and 3 children.

Kurt Bettenhausen

Senior Vice President and Future of Automation Head, Siemens Corporate Technology

Kurt D. Bettenhausen is Senior Vice President and Future of Automation Head of Siemens Corporate Technology. Located in Princeton, New Jersey in the USA, Corporate Technology is one of several Siemens Corporate Technology research and development centers worldwide. Since its founding in 1977, it has helped pioneer a broad range of advancements in major industries, delivering innovations to the Siemens global family as well as government agencies, academic institutions, and other organizations. Before joining Corporate Technology, Dr. Bettenhausen headed up the Engineering and Consulting Business of Siemens’ Industrial Automation Division based in Frankfurt, Germany. He began his career in the research and technology department of Hoechst. Later, he held senior positions in marketing, sales and product management at Axiva. Dr. Bettenhausen is a member of the advisory board at the University of California, Berkeley’s College of Engineering, member of the CITRIS and the Banatao Institute, and is Chairman of the Association of German Engineers’ Measurement and Automation Technology Organization, VDI/VDE-GMA. Bettenhausen attained a master’s degree and a Ph.D. in electrical engineering from Darmstadt University of Technology.

Chris Pfaff

CEO, Tech/Media LLC

Chris Pfaff is a leading new media and technology producer and strategist. He is renowned for integrating leading-edge technology into the media and entertainment community. He was the first to use IRC for an interactive corporate webcast; produced one of the first DVDs, in March, 1997; produced the first HD animated logo; produced numerous multipoint broadband events in the late-1990s; produced some of the first mobile short films in 2002-2003, and produced the first Twitter Wall in 2011. His company, Chris Pfaff Tech/Media LLC, provides strategy and marketing services for leading technology service providers, technology firms, and new media companies worldwide. Since founding Chris Pfaff Tech/Media LLC in 2002, Chris has represented a wide range of clients, including strategic ventures from Eastman Kodak, PRIMEDIA, Cantor Telecom, and ASCAP, and firms ranging from mobile content distributor Thumbplay, video encoding firm On2 Technologies (sold to Google), and 3D face and body animation production studio face2face animation. He leads a global team that works with a large, and growing, number of North American and European ventures. Chris was one of the founders of the Producers Guild of America (PGA) New Media Council East, and served as chairman of the group from 2007-2013. He served as the vice chairman of the national PGA New Media Council from 2011-2013, for which he served as a delegate from 2006-2013, and also served as a delegate on the PGA Board of Directors from 2008-2013. Prior to launching Chris Pfaff Tech/Media, Chris was involved with the early-stage ventures GeoVideo Networks and MobileQ, and previously had helped launch more than 16 ventures with the Lucent New Ventures Group and Bell Labs, including Lucent Digital Radio (now iBiquity Digital), SyChip (sold to Murata), e-Ink, Flarion (sold to Qualcomm), and savaJe (sold to Sun Microsystems), among many others. While at AT&T Corp., he helped launch AT&T WorldNet Service and the AT&T NetWare Connect Service, and also helped launch the AT&T Personal Online Services division. Prior to this, he represented such clients as Sony Electronics; Viacom New Media, Sharp Electronics, and Kyocera, among others. He began his career in the music industry, representing clients including Yamaha Corporation; Hal Leonard Publishing, and working with a wide range of musical artists and producers, including such notable figures as Walter Becker, Chick Corea, Wynton Marsalis, and Phil Ramone.

K.P. (Suba) Subbalakshmi

Founding Director, Stevens Institute for Artificial Intelligence

Prof. K.P. (Suba) Subbalakshmi is the Founding Director of the Stevens Institute for Artificial Intelligence as well as a Professor in the Department of Electrical and Computer Engineering, Stevens Institute of Technology. Suba was named a Jefferson Science Fellow in 2016. As a part of this fellowship, she spent the 2016-17 academic year as a science and technology advisor to the US Department of State. Suba is a Fellow of the National Academy of Inventors. She is also a Co-Founder of two technology start-up companies. She is a recipient of a New Jersey Inventors Hall of Fame Innovator Award for her work on detecting deception from text content. She is a Founding Associate Editor of the IEEE Transactions on Cognitive Communications and Networking and the Founding Chair of the Security Special Interest Group in IEEE COMSOC’s Technical Committee on Cognitive Networks (TCCN). She has given several keynote addresses, tutorials and short courses as well as served as a panelist in several prestigious international conferences. She serves/has served as an Associate Editor for several IEEE journals and frequently organizes international conferences and workshops

Michael Kirchhoff

Chief Innovation Officer, Cooper University Health Care

Michael Kirchhoff, MD is the Chief Innovation Officer at Cooper University Health Care where he actively practices Emergency Medicine as an Associate Professor at the Cooper Medical School of Rowan University. He has been on key teams that have brought new business units to Cooper including Emergency Medicine Contracted Services, Urgent Care, Emergency Medical Services, and the Helicopter Transport Program. He has developed applications for Graduate Medical Education procedure tracking, hospital coding/charging and revenue cycle audit, external provider post-acute communication, and ED over-crowding surveillance. He currently helps to drive organizational intellectual property management and development, outside business development partnerships, and inter-institutional resource sharing. He currently serves on the board of Stem Plant LLC, an implantable device company. He has served as the Medical Director for the Emergency Department, Urgent Care, Simulation Lab, and EM Ultrasound. Dr. Kirchhoff is the Patient Safety Officer for the health system as well as board eligible for Medical Informatics and is active in business intelligence, reporting, and planning.

Chris Sullens

CEO, CentralReach

Chris Sullens is the Chief Executive Officer of CentralReach and is leading the company in its mission to provide an end-to-end platform of software and services that enable Applied Behavior Analysis (ABA) clinicians and educators to produce superior client outcomes for people with autism. Sullens brings decades of experience to the company and has a proven track record of building strong company cultures and taking customer-centric technology companies, like CentralReach, to the next level. In the 6 months since he joined, CentralReach has already won four awards - the Deloitte Technology Fast 500, NJBiz Fast 50, NJBiz Best Places to Work and Best in Biz Company of the Year - demonstrating the positive effects of the investments the company is making in its people, process, systems and client satisfaction initiatives. Prior to CentralReach, Sullens spent 10 years as President and CEO of WorkWave, a leading provider of cloud-based software solutions for the field service and last mile logistics industries, which was recently acquired by IFS, an EQT-backed, global enterprise software provider based in Sweden. Sullens was responsible for developing the vision, setting the strategy and driving the execution for the company since joining in 2008. During his time there, Sullens transformed WorkWave through significant investment and 11 strategic acquisitions from a single product, single market, predominantly on- premise company, to a multi-product and multi-market SaaS company that is now the leading provider of cloud-based solutions for the field service and last mile logistics industries. Sullens grew employee count from 38 to almost 300 and increased revenue by 800% while maintaining double-digit EBITDA margins, creating an award-winning culture and building a world class SaaS leadership team. During his tenure, the company was a seven-time winner of NJ Best Places to Work, named an Inc. Best Place to Work and a five-time Inc. 5000 fastest growth award winner among other awards. Sullens was also named 2016 EY Entrepreneur of the Year in NJ for Software Services and won a Stevie award for People Focused CEO of the Year in 2017. He has a B.S. in Mechanical Engineering from Virginia Tech and an M.B.A. with Honors in Finance, Strategy and Entrepreneurship from the University of Chicago Booth School of Business.

Merwan Mereby

Vice President of Technology & Strategic Partnerships, Panasonic

Merwan Mereby is Panasonic Corporation of North America’s Vice President of Technology & Strategic Partnerships. Mr. Mereby has more than twenty years of experience within Panasonic, developing and deploying strategies to create new business opportunities, technology and business innovation, to contribute to revenue growth, expand market footprint and increase profitability. Mr. Mereby has led the company’s efforts in acquiring new technologies such as Artificial Intelligence, Machine Learning, Over the top content distribution and targeted advertising platform, he also led the global incubation, expansion and innovation of connected products, identifying and implementing strategies to enable development of cloud-based compelling applications, services and solutions. All of these efforts contributed to Panasonic’s transformation and innovation. Additionally, Mr. Mereby has led the Software and Analytics Solutions Group in North America to help Panasonic transform to a total solutions business and to build an IoT platform and predictive analytics solution. In 2014 Mr. Mereby took on the leadership of the Smart TV Alliance, accepting the role of President. The Smart TV Alliance’s mission is to create a large and productive ecosystem for application development, enabling developers to write applications once for many different platforms and providing consumers with a rich source of content and services. Mr. Mereby is also a member of the Board of Directors of Arimo LLC, a provider of Artificial Intelligence and Machine learning solutions and he is also a Board of Directors of Xumo LLC, a provider of innovative solution for over the top content and targeted advertising for connected devices. Mr. Mereby earned a Bachelor of Science in Business Administration from the University of Louisiana.

Tiffany McLaud

Head of the Consumer Health Accelerator, Bayer Consumer Healthcare

Tiffany McLaud is the Head of the Consumer Health Accelerator for Bayer Consumer Healthcare. The Consumer Health Accelerator is a dedicated, cross-functional unit whose purpose is to gather and interpret early market signals to identify potential emerging trends, brands, capabilities and business models that have the potential to generate growth for Bayer Consumer Health US. Once identified, the team then activates against those trends and quickly executes to realize the growth. She joined Bayer in April 2017 as Vice President of Sales Strategy & Operations, where she was responsible for leading an integrated team that spans Sales Strategy, Shopper Marketing, Sales Planning & Effectiveness, and Sales Operations. Prior to Bayer, Tiffany served as Vice President of Marketing for CB Fleet Laboratories where she implemented strategic cross-functional teams for each category, successfully strengthening brand pipelines and achieving brand productivity targets. Previously, she oversaw the U.S. Healthcare portfolio for Reckitt Benckiser (RB) and was directly responsible for driving substantial category and brand growth across the RB Healthcare portfolio. She has also held various global and U.S. leadership roles at Pfizer Consumer Healthcare and Wyeth Consumer Healthcare. Tiffany has a Masters in Corporate & Organizational Communications from Fairleigh Dickinson University and a B.A in Political Science from Colgate University. She lives in Mendham, New Jersey with her husband, Steve, her three sons, twins Jack and Collyer, and Teddy, as well as their dog, Doc.

Steve LeVine

Future Editor, Axios

Steve LeVine is the future editor at Axios. Prior to Axios, LeVine was Washington Correspondent for Quartz, the mobile-first startup launched in 2012 by Atlantic Media. Steve is also a Future Tense Fellow at the New America Foundation and an adjunct professor at Georgetown University, where he teaches energy security in the graduate-level Security Studies Program. Previously, Steve was a foreign correspondent for 18 years in the former Soviet Union, Pakistan and the Philippines, running a bureau for The Wall Street Journal, and before that writing for The New York Times, the Financial Times and Newsweek. He is also an author of three books.

Anastassia Loukina

Research Scientist, ETS

Anastassia Loukina is a research scientist in the Research and Development division at Educational Testing Service (ETS) in Princeton NJ. ETS develops, administers and scores more than 50 million tests annually in more than 180 countries at more than 9,000 locations worldwide. The NLP & Speech group at ETS develops technology for automated scoring of open-ended items, classroom support tools for teachers, and tools that can aid in the test development process. Since joining ETS, Anastassia has led the research to improve the validity, reliability and fairness of speech-based educational application and made key contribution to successful launch of several automated scoring system. She published more than 40 papers and book chapters, holds several patents and frequently attends international conferences and workshops. She is member of several professional organizations and a co-chair for the Industry Track of 2019 Annual Conference of the North American Chapter of the Association for Computational Linguistics. Before joining ETS, Anastassia worked at the Oxford University Phonetics Laboratory where she conducted research and taught graduate and undergraduate courses in linguistics and phonetics. She holds MPhil and DPhil from the University of Oxford.

Bob Zambon

Director of Real World Innovation, Janssen Pharmaceuticals

Dr. Zambon is the Director, Real World Innovation, in Janssen Scientific Affairs at Janssen Pharmaceuticals. In his role, Dr. Zambon leads and supports strategic innovation initiatives for Janssen Scientific Affairs focused on the usage of innovative technologies, analytics, data, and partnerships to accelerate and advance real world research and initiatives across all of Janssen’s therapeutic areas. Dr. Zambon has close to twenty years of experience in the life sciences industry with experience in strategy development, program management, clinical research, product development, sales force training, client management, regulatory affairs, analytics, and market research. He’s led and supported research programs in the areas of cardiology, orthopedics, immunology, infectious disease, and medical countermeasures. Dr. Zambon received his Ph.D. in Molecular & Cell Biology at the University of Maryland and his B.S. in Biotechnology at Rutgers University.

Gary Rosenblum

President, Oticon

Gary Rosenblum has been President of Oticon, Inc. since October of 2016. Gary is responsible for driving forward Oticon’s leadership in innovation, product quality and customer support. He brings a rich understanding of how customers and consumers are adapting to a changing healthcare environment. Prior to Oticon, Gary ran several medical device and consumer healthcare businesses for Fortune 500 companies including Johnson & Johnson, Abbott Labs, and Pfizer. Gary earned his MBA from Cornell University and his BA in Psychology and History from Washington University in St. Louis.

Dan Tinkoff

Global Leader: Data & Analytics Practice, McKinsey

Dan is the global leader of McKinsey’s Data & Analytics Practice for pharmaceuticals and life sciences companies. He leverages expertise in data analytics and deep industry knowledge to advise life sciences business leaders and Chief Digital/ Analytics Officers on their digital & analytics strategies and operating models. He also works extensively with digital & analytics organizations on how they transform and innovate their capabilities for today’s dynamic healthcare and technology landscape. Dan has 13 years of healthcare consulting experience, including extensive experience working with life sciences companies on strategy and business transformation.

Judy Comitto

Vice President IT and CIO, Trinitas Regional Medical Center

Judy Comitto is Vice President IT and CIO at Trinitas Regional Medical Center a full-service healthcare facility serving Union County New Jersey. Operating on two major campuses, Trinitas Regional Medical Center has 531 beds, including a 120-bed long-term care center. Trinitas Regional Medical Center is proud to offer state-of-the-art medicine backed by compassion and competence. Responsibilities include strategic planning, systems and programming, user training and support, security and business recovery and telecommunications. Ms. Comitto earned a bachelor’s degree from Hunter College in NYC as well as a Master of Public Administration with a concentration in Healthcare from LIU and has spent 30+ years in healthcare. In addition to her responsibilities at TRMC she is also a Vice Chair of Jersey Health Connect (major HIO in NJ), member of NJ HIMSS and a Chime member.

Eamon Gallagher

Program Director, University City Science Center

Eamon Gallagher works with several entrepreneurship and startup initiatives in and around Philadelphia, primarily with commercialization programs at the University City Science Center. As Program Director at ic@3401, Philadelphia’s largest community of funded start-ups, he works with startups to speed their development from teams of 2 with an idea to teams of 8 with a company. He is an attorney and serves as Director of Drexel Law School’s Entrepreneurial Law Clinic. Eamon’s first career was in corporate recruiting. He earned a J.D. from Drexel Law with a concentration in Business and Entrepreneurship Law. He also holds a B.S. in Public Policy and a B.A. in Philosophy from the University of Rhode Island.

Jim Gunton

Managing Partner, Tech Council Ventures

Jim Gunton, Managing Partner, of Tech Council Ventures has invested in privately-held growth technology companies for more than 20 years. Before co-founding in 2001 the $80 million NJTC Venture Fund, Jim was a partner at Edison Venture Fund and a manager at Oracle Corporation in the Silicon Valley. He served formerly as a Governor of the National Association of Small Business Investment Companies (NASBIC). Jim earned a BS from Stanford University and an MBA with distinction from Duke University. He has served on the board of numerous private and public companies including Achieve3000, Amber Road (NYSE: AMBR), CytoSorbents (NASDAQ: CTSO), InstaMed, IntegriChain and CareGain. Tech Council Ventures is a venture fund investing in early and expansion stage companies across all industries in the Mid-Atlantic region. The fund invests $500K to $2M initially and provides additional support throughout the growth of the business. Tech Council Ventures’ principals all have 20+ years investing and building promising, rapid growth companies. The fund is affiliated with one of the largest and most active technology councils in the US, the NJ Tech Council, providing for its portfolio investments an unmatched network of customer, key team recruits, business partner and service provider connections.

David Sorin

Partner, McCarter & English

Dave Sorin is an office managing partner of McCarter & English and Co-Chair of the Venture Capital & Emerging Growth Companies practice. His national practice focuses primarily on privately- and publicly-owned startup, early stage, emerging growth, and middle market technology, tech-enabled and life science enterprises, as well as the investors, executives, and boards of directors who support and lead them. Dave has a long track record of successful representation of growth companies, having been repeatedly recognized by well-known periodicals for a unique combination of legal acumen and sound business judgment. He also brings to bear his broad range of knowledge and experience in counseling enterprises and investors in diverse emerging growth markets, technology industries (including software, artificial and augmented intelligence, VR/AR, information technology, e-commerce, cybersecurity and communications), and life sciences. Dave is a thought leader in the emerging areas of blockchain, smart contracts and digital currencies—not only talking the talk by participating in speaking engagements and authoring articles, but walking the walk by representing venture capital investors and companies employing such technologies, and working on matters in connection with utility and security tokens, SAFTs, and ICOs (including under Regulations D and A). One industry-leading publication has recognized Dave as one of New Jersey’s top 100 business people, categorizing him within an “elite group” of executives who “are the voices of their industries.” He was later identified by another industry publication as one of the region’s “top deal makers.” Chambers USA, an international guide to lawyers and law firms, called Dave the State’s top corporate lawyer, and, in 2017, a national leader in the representation of startup and emerging growth companies. SmartCEO Magazine named McCarter the large law firm of the year in the tech and tech-enabled industry sector and named Dave the leading lawyer in the industry. In addition, Dave Sorin received the Star Influencer Award at SmartCEO’s Centers of Influence Event. Dave co-founded the law firm of SorinRand in 2009, was Managing Partner of the New Jersey and New York law offices of Buchanan Ingersoll Professional Corporation and of the Princeton office of Hale & Dorr LLP (now WilmerHale LLP), as well as a corporate practice area Vice-Chair. In addition, he serves as an adjunct professor, teaching a course on high-growth corporate transactions at the Cornell Law School Technology Law LLM Program. Previously, Dave served as a Clinical Associate Professor of Law at Drexel University, teaching Entrepreneurial Law, Legal Issues for Start-Ups, Venture Capital and Corporate Governance. He also served as an Adjunct Professor of Law at Seton Hall University School of Law, teaching Accounting for Lawyers and Mergers & Acquisitions. He began his legal career at Davis Polk & Wardwell. The realities of the 21st century economy, dramatic advances in technology and rigorous analysis of their effects on the business and legal marketplace convinced Dave that service to startup, early stage, emerging growth and middle market enterprises is largely incompatible with the cost infrastructure, high leverage, and fee schedules generally associated with today’s law firm model. He and his partners founded SorinRand to meet the new business realities head-on, reinventing law firm practice to help clients achieve their goals, sensibly. Together, they joined McCarter & English to leverage McCarter’s geographical scale, size, and breadth of services to provide clients the many disciplines they require throughout their business lifecycles, while retaining the unique delivery model and value proposition offered by SorinRand. Dave, who is a frequent speaker, panelist, and author on issues of interest to the emerging growth and middle market sectors, also is a Certified Public Accountant. In 2016, he co-founded entreprenYOURS, Inc., a new accelerator program for startup tech and tech-enabled companies in New York and New Jersey, characterized by a unique system of cross-equity ownership designed to foster collaboration and community among the accelerator’s portfolio companies. In addition, he helped to co-found a new venture capital fund focused on investing in early-stage and emerging growth companies in New Jersey and the surrounding region that have demonstrated early traction in consumer-facing technologies and Internet-of-Things (IoT) verticals, among other tech and tech-enabled industry sectors. Professional Accomplishments: • Named a national leader in the representation of startup and emerging growth companies by Chambers, 2017-2018; • Recognized by New Jersey Law Journal as a Distinguished Leader of the Bar, 2017; • Received the Star Influencer Award by SmartCEO, 2016; • Named Leading Lawyer in the Tech and Tech-Enabled Industry Sector by SmartCEO; • Named a Super Lawyer in both Metro NY and NJ in Securities & Corporate Finance, Business/Corporate, Mergers & Acquisitions in 2012-2018; • Inducted into the New Jersey Technology Council Hall of Fame, 2011; • Recipient of the NJTC John H. Martinson Technology Supporter Award; • Recipient of the Legend of Technology Award from NJTC.

Jack Quigley

Chief Architect, Horizon BCBS of NJ

Jack Quigley is the Chief Architect at Horizon Blue Cross Blue Shield of New Jersey. Jack is accountable for all disciplines across Horizon’s IT Architecture, which includes Platform and Technical Architecture, Data Architecture, Solutions Architecture and Architecture Governance. He joined Horizon in 2016 as Director of Data Architecture, prior to assuming his current role in 2018. Jack’s broad experience includes development and leadership roles in telecommunications, high tech, health plans and PBM. He holds a bachelor degree in computer science from Rutgers University, New Brunswick, and a master’s degree from Stevens Institute of Technology, Hoboken. Jack resides in New Jersey, with his wife Maureen and their four sons.

Colleen Riley

Vice President, Science and Technology for the Joint Replacement Division, Stryker

Dr. Colleen Riley is the Vice President, Science and Technology for the Joint Replacement Division of Stryker Orthopaedics where she is responsible for leading the Advanced Technology and Regulatory Affairs groups. Prior to joining Stryker in 2014, Colleen held a rich career in a number of senior leadership positions in Research and Development, Medical, Clinical and Regulatory Affairs. She played integral roles in leading teams in all stages of global product and technology development in medical devices, pharmaceuticals, and over the counter (OTC) products. She also brings progressive experience as a scientist, practicing clinician and educator. She has held faculty positions at Indiana University and served on numerous boards. In 2007, she was selected as one of the top “20 Most Influential Women in the Optical Industry”. Colleen is a Fellow and a Contact Lens Diplomate in the Section on Cornea, Contact Lenses and Refractive Technologies of the American Academy of Optometry. Colleen attended Indiana University where she received her Doctor of Optometry, Master of Science in Physiological Optics and a Bachelor’s degree in Chemistry.

Dan Borok

Co-Founder & Managing Partner, Newark Venture Partners

Dan is a co-Founder and Managing Partner at Newark Venture Partners. He has been in the venture space since 2005, most recently as a Partner at Millennium Technology Value Partners. He was previously a business analyst at Google. Dan focuses on B2B tech, including themes such as healthcare, insurance, future of work and enterprise automation. Dan has an MBA from Columbia Business School and a BA from University of Vermont.

Sanjay Macwan

SVP Enterprise Engineering and Networks, Vonage

In his role as SVP, Enterprise Engineering and Networks, Sanjay Macwan leads Vonage's enterprise platform and engineering teams to drive innovation and new development in the Company's solutions for Enterprise customers. With more than 20 years of experience in technology leadership, strategy and execution, Sanjay has built and led highly successful technology innovation programs that have delivered transformation, operational efficiency and a sustained culture of innovation across multiple industries. Prior to Vonage, Sanjay was the Senior Vice President and Chief Technology Officer at NBCUniversal focused on driving innovation across all lines of business. He helped the company deliver next- generation content experiences leveraging emerging technologies including virtual reality, augmented reality, ultra-high definition, IoT, machine learning and more across various platforms. Earlier in his career, Sanjay also led AT&T’s Technology Council in the Chief Technology Office where he was responsible for accelerating technology innovation for the company and its ecosystem. During many years at AT&T Labs, he also led large scale R&D in multimedia, mobility, information security and cloud. Sanjay is the founder of The Holmdel Idea Summit (THIS) – a STEAM program connecting talented high-school and college students, accomplished innovators and business leaders from our community. Vonage is a proud sponsor of this community initiative, which was held for the first time in 2017.

Tim Rollender

Senior Venture Officer

Timothy Rollender is a Senior Venture Officer in the EDA’s TLS division, where he is responsible for marketing the Edison Innovation Fund and technology-led state incentives to potential applicants, consultants, technology transfer offices and partnering organizations. Tim joined the EDA after working as a Senior Analyst for asset management firm Hirtle, Callaghan & Co., where he led due diligence on alternative investment opportunities. He also worked as an Investment Analyst for the New Jersey Department of the Treasury, Division of Investment, and has extensive experience in private and public equity investing. Tim earned an MBA from Temple University’s Fox School of Business and a BA in Economics and Philosophy from Drew University in Madison.

Ibrahim Mohamed

Head of Enablement, Google Cloud

Ibrahim Mohamed is the Head of Enablement at Google Cloud. In this role, he works with the global strategic partnerships on competency and solutions development differentiated by Google Cloud AI, Data, Analytics and Infrastructure capabilities. Prior to Google, Ibrahim worked at Microsoft, VMware and LinkedIn in various software development, product management and solutions engineering leadership roles with Microsoft Azure, VMware Cloud Foundation and LinkedIn Platform as a Service.

Brian McLaughlin

Director of the Rutgers Center for Cognitive Science

Brian P. McLaughlin is Distinguished Professor of Philosophy and Cognitive Science and the Director of the Rutgers Center for Cognitive Science. He works in the philosophy of mind and has written on robot ethics.

Cathy Bennett

CEO, NJHA

Cathleen D. Bennett, Esq., took the helm November 9, 2017, as president and CEO of the New Jersey Hospital Association, a nonprofit trade association representing New Jersey’s hospitals, health systems, behavioral healthcare systems, rehabilitation hospitals, psychiatric hospitals, assisted living, nursing homes and other healthcare providers that provides leadership on quality and patient safety, education and advocacy in both Washington, D.C. and in Trenton. As CEO, Bennett oversees NJHA, the Health Research and Educational Trust of New Jersey, a not-for-profit affiliate that promotes continuing education, patient safety, quality improvement and research; and the for-profit Healthcare Business Solutions, which provides group purchasing and other business solutions for healthcare providers. She co-founded Q3HIP, LLC in 2018 with a focus on improving quality of care, patient safety and education and leveraging the collective capabilities of the Hospital Associations of New Jersey, Pennsylvania and Ohio. Prior to being selected as CEO of NJHA, Bennett served as New Jersey’s 20th Health Commissioner.

Array
(
    [0] => WP_Post Object
        (
            [ID] => 5
            [post_author] => 1
            [post_date] => 2019-01-28 17:49:15
            [post_date_gmt] => 2019-01-28 17:49:15
            [post_content] => 
            [post_title] => Joseph Scott
            [post_excerpt] => As the Executive Vice President for Health Care Transformation for RWJBarnabas, Mr. Scott leads strategic planning and implementation, business development, innovation and population health for the system.  He joined Barnabas Health in 2014 after a successful merger between Liberty Health and the Barnabas system. In 2016 he continued serving as the President and CEO at Jersey City Medical Center while beginning work at the system level to formalize the strategic planning process. 
   Mr. Scott served as the President and CEO of Jersey City Medical Center from 2008 until 2018 and holds board certification in healthcare management as a Fellow of the American College of Healthcare Executives (FACHE). Under his visionary leadership, Jersey City Medical Center received more than 35 awards and recognition for quality services, patient safety, and community outreach that include the Joint Commission Top Hospital Performer Award, the American Nurses Credentialing Center’s Magnet Award for Nursing Excellence designation in 2008 and re-designation in 2014 and 2018.  
In 2015, Jersey City Medical Center earned the prestigious Vision of Performance Excellence Award, the state-level Malcolm Baldrige Award. The Medical Center’s EMS became the first triply- accredited Emergency Medical Services in the United States. 
The Independent Leapfrog Group awarded Jersey City Medical Center an “A” rating in Hospital Safety and Quality for twelve consecutive rating periods (2012-2017). In 2017, Jersey City Medical Center was named a Top Teaching Hospital by the Leapfrog group. 
Beginning in 2014, and every year since, the hospital has received national LGBTQ HEI certification, demonstrating commitment to the diversity of the workforce, the community and healthcare equality. The organization was presented with the National Diversity in Leadership Award by the American Hospital Association. 
Mr. Scott is committed to making a difference in his local community as well as the future of health care and has served as Chairman of the Board of the Hudson County Chamber of Commerce and past Chair of Hospital Alliance of New Jersey, Inc.    
As an active leader in his community he volunteers his time and has assumed several leadership positions with community organizations including the March of Dimes, the American Heart Association, and Susan G. Komen Race for the Cure and serves as a Board Member of Big Brothers/Big Sisters of Essex, Union and Hudson Counties. The Governor appointed Joe to the Board of Trustees for New Jersey City University. On a national level, Mr. Scott is Chairman of the Board of America’s Essential Hospitals and is past Chairman of the America’s Essential Hospitals Policy Committee. 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => 5
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-02 13:25:31
            [post_modified_gmt] => 2019-04-02 13:25:31
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=5
            [menu_order] => 0
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [1] => WP_Post Object
        (
            [ID] => 79
            [post_author] => 1
            [post_date] => 2019-04-01 14:57:20
            [post_date_gmt] => 2019-04-01 14:57:20
            [post_content] => 
            [post_title] => Christopher White
            [post_excerpt] => Chris leads the Algorithms, Analytics, Augmented Intelligence and Devices (AAAID) research lab in Bell Labs. He joined Bell Labs in 1997 after graduating with a Ph.D. in theoretical quantum chemistry from the University of California in Berkeley, California. His research interests include the development of computational models and methods for the simulation and control of interesting physical and digital systems. This has included work in areas ranging from linear scaling quantum chemistry simulations, to the design of new optical devices, to the global control of transparent optical mesh networks and to understanding and facilitating the propagation of ideas in organizations.   In addition to the management of an international team of world-class researchers, Dr. White’s current work focuses on the creation of assisted thinking tools that leverage structural similarity in data with the goal of augmenting human intelligence.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => 79
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-04 19:50:29
            [post_modified_gmt] => 2019-04-04 19:50:29
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=79
            [menu_order] => 2
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [2] => WP_Post Object
        (
            [ID] => 29
            [post_author] => 1
            [post_date] => 2019-02-07 16:46:07
            [post_date_gmt] => 2019-02-07 16:46:07
            [post_content] => 
            [post_title] => Alastair Binnie
            [post_excerpt] => Alastair Binnie is Head of Information Technology for Research & Development at Bristol-Myers Squibb.   In this role he is accountable for planning and delivering all aspects of IT’s value proposition to BMS R&D, which includes digital platforms supporting discovery, preclinical, translational medicine, clinical development, regulatory sciences, pharmacovigilance, and medical affairs.   His mission is to enable R&D by providing the right tools and the right data, to the right scientists, at the right time.    
He joined BMS in 1999 as the leader of the Discovery Automation team in Wallingford, Connecticut, and progressed through a range of leadership roles in research technology and IT, assuming his current role in 2015. 
From 1994-99 he led the Discovery Technologies group at Glaxo Wellcome R&D in the UK.  
Prior to joining the pharmaceutical industry, Alastair worked as a design engineer in the space industry, developing instrumentation for microgravity research for the European Space Agency.    
He is a current or recent Board member of global life-science technology industry groups, including PRISME, the Society of Laboratory Automation and Screening, and the Pistoia Innovation Alliance.  He represents BMS on the New Jersey Technology Council.  
Alastair grew up in Scotland.  He has degrees in mechanical engineering, design engineering and industrial design from Brunel University, Imperial College of Science and Technology, and the Royal College of Art.  He now lives in Princeton with his wife Zoe and 3 children.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => alastair-binnie
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-02-07 16:48:08
            [post_modified_gmt] => 2019-02-07 16:48:08
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=29
            [menu_order] => 3
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [3] => WP_Post Object
        (
            [ID] => 32
            [post_author] => 1
            [post_date] => 2019-02-12 14:45:23
            [post_date_gmt] => 2019-02-12 14:45:23
            [post_content] => 
            [post_title] => Kurt Bettenhausen
            [post_excerpt] => Kurt D. Bettenhausen is Senior Vice President and Future of
Automation Head of Siemens Corporate Technology.
Located in Princeton, New Jersey in the USA, Corporate Technology
is one of several Siemens Corporate Technology research and
development centers worldwide. Since its founding in 1977, it has
helped pioneer a broad range of advancements in major industries,
delivering innovations to the Siemens global family as well as
government agencies, academic institutions, and other
organizations.
Before joining Corporate Technology, Dr. Bettenhausen headed up the Engineering and Consulting
Business of Siemens’ Industrial Automation Division based in Frankfurt, Germany. He began his career
in the research and technology department of Hoechst. Later, he held senior positions in marketing,
sales and product management at Axiva.
Dr. Bettenhausen is a member of the advisory board at the University of California, Berkeley’s College
of Engineering, member of the CITRIS and the Banatao Institute, and is Chairman of the Association of
German Engineers’ Measurement and Automation Technology Organization, VDI/VDE-GMA.
Bettenhausen attained a master’s degree and a Ph.D. in electrical engineering from Darmstadt
University of Technology.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => kurt-bettenhausen
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-02-12 14:45:23
            [post_modified_gmt] => 2019-02-12 14:45:23
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=32
            [menu_order] => 4
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [4] => WP_Post Object
        (
            [ID] => 34
            [post_author] => 1
            [post_date] => 2019-02-13 14:37:56
            [post_date_gmt] => 2019-02-13 14:37:56
            [post_content] => 
            [post_title] => Chris Pfaff
            [post_excerpt] => 
Chris Pfaff is a leading new media and technology producer and strategist. He is renowned for integrating leading-edge technology into the media and entertainment community. He was the first to use IRC for an interactive corporate webcast; produced one of the first DVDs, in March, 1997; produced the first HD animated logo; produced numerous multipoint broadband events in the late-1990s; produced some of the first mobile short films in 2002-2003, and produced the first Twitter Wall in 2011.
His company, Chris Pfaff Tech/Media LLC, provides strategy and marketing services for leading technology service providers, technology firms, and new media companies worldwide. Since founding Chris Pfaff Tech/Media LLC in 2002, Chris has represented a wide range of clients, including strategic ventures from Eastman Kodak, PRIMEDIA, Cantor Telecom, and ASCAP, and firms ranging from mobile content distributor Thumbplay, video encoding firm On2 Technologies (sold to Google), and 3D face and body animation production studio face2face animation. He leads a global team that works with a large, and growing, number of North American and European ventures.
Chris was one of the founders of the Producers Guild of America (PGA) New Media Council East, and served as chairman of the group from 2007-2013. He served as the vice chairman of the national PGA New Media Council from 2011-2013, for which he served as a delegate from 2006-2013, and also served as a delegate on the PGA Board of Directors from 2008-2013.
Prior to launching Chris Pfaff Tech/Media, Chris was involved with the early-stage ventures GeoVideo Networks and MobileQ, and previously had helped launch more than 16 ventures with the Lucent New Ventures Group and Bell Labs, including Lucent Digital Radio (now iBiquity Digital), SyChip (sold to Murata), e-Ink, Flarion (sold to Qualcomm), and savaJe (sold to Sun Microsystems), among many others. While at AT&T Corp., he helped launch AT&T WorldNet Service and the AT&T NetWare Connect Service, and also helped launch the AT&T Personal Online Services division. Prior to this, he represented such clients as Sony Electronics; Viacom New Media, Sharp Electronics, and Kyocera, among others. He began his career in the music industry, representing clients including Yamaha Corporation; Hal Leonard Publishing, and working with a wide range of musical artists and producers, including such notable figures as Walter Becker, Chick Corea, Wynton Marsalis, and Phil Ramone. 

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => chris-pfaff
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-02-13 14:37:56
            [post_modified_gmt] => 2019-02-13 14:37:56
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=34
            [menu_order] => 5
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [5] => WP_Post Object
        (
            [ID] => 44
            [post_author] => 1
            [post_date] => 2019-02-19 16:30:53
            [post_date_gmt] => 2019-02-19 16:30:53
            [post_content] => 
            [post_title] => K.P. (Suba) Subbalakshmi
            [post_excerpt] => Prof. K.P. (Suba) Subbalakshmi is the Founding Director of the Stevens Institute for Artificial Intelligence as well as a Professor in the Department of Electrical and Computer Engineering, Stevens Institute of Technology. Suba was named a Jefferson Science Fellow in 2016. As a part of this fellowship, she spent the 2016-17 academic year as a science and technology advisor to the US Department of State. Suba is a Fellow of the National Academy of Inventors. She is also a Co-Founder of two technology start-up companies. She is a recipient of a New Jersey Inventors Hall of Fame Innovator Award for her work on detecting deception from text content. She is a Founding Associate Editor of the IEEE Transactions on Cognitive Communications and Networking and the Founding Chair of the Security Special Interest Group in IEEE COMSOC’s Technical Committee on Cognitive Networks (TCCN). She has given several keynote addresses, tutorials and short courses as well as served as a panelist in several prestigious international conferences. She serves/has served as an Associate Editor for several IEEE journals and frequently organizes international conferences and workshops
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => 44
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-02-19 16:31:43
            [post_modified_gmt] => 2019-02-19 16:31:43
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=44
            [menu_order] => 6
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [6] => WP_Post Object
        (
            [ID] => 133
            [post_author] => 1
            [post_date] => 2019-05-03 13:24:54
            [post_date_gmt] => 2019-05-03 13:24:54
            [post_content] => 
            [post_title] => Michael Kirchhoff
            [post_excerpt] => Michael Kirchhoff, MD is the Chief Innovation Officer at Cooper University Health Care where he actively practices Emergency Medicine as an Associate Professor at the Cooper Medical School of Rowan University. 
He has been on key teams that have brought new business units to Cooper including Emergency Medicine Contracted Services, Urgent Care, Emergency Medical Services, and the Helicopter Transport Program. He has developed applications for Graduate Medical Education procedure tracking, hospital coding/charging and revenue cycle audit, external provider post-acute communication, and ED over-crowding surveillance.
He currently helps to drive organizational intellectual property management and development, outside business development partnerships, and inter-institutional resource sharing. He currently serves on the board of Stem Plant LLC, an implantable device company.
He has served as the Medical Director for the Emergency Department, Urgent Care, Simulation Lab, and EM Ultrasound.
Dr. Kirchhoff is the Patient Safety Officer for the health system as well as board eligible for Medical Informatics and is active in business intelligence, reporting, and planning.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => michael-kirchhoff
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-05-03 13:24:54
            [post_modified_gmt] => 2019-05-03 13:24:54
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=133
            [menu_order] => 7
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [7] => WP_Post Object
        (
            [ID] => 51
            [post_author] => 1
            [post_date] => 2019-03-08 14:24:07
            [post_date_gmt] => 2019-03-08 14:24:07
            [post_content] => 
            [post_title] => Chris Sullens
            [post_excerpt] => Chris Sullens is the Chief Executive Officer of CentralReach and is leading the company in its mission to provide an end-to-end platform of software and services that enable Applied Behavior Analysis (ABA) clinicians and educators to produce superior client outcomes for people with autism. Sullens brings decades of experience to the company and has a proven track record of building strong company cultures and taking customer-centric technology companies, like CentralReach, to the next level. In the 6 months since he joined, CentralReach has already won four awards - the Deloitte Technology Fast 500, NJBiz Fast 50, NJBiz Best Places to Work and Best in Biz Company of the Year - demonstrating the positive effects of the investments the company is making in its people, process, systems and client satisfaction initiatives.

Prior to CentralReach, Sullens spent 10 years as President and CEO of WorkWave, a leading provider of cloud-based software solutions for the field service and last mile logistics industries, which was recently acquired by IFS, an EQT-backed, global enterprise software provider based in Sweden. Sullens was responsible for developing the vision, setting the strategy and driving the execution for the company since joining in 2008. During his time there, Sullens transformed WorkWave through significant investment and 11 strategic acquisitions from a single product, single market, predominantly on- premise company, to a multi-product and multi-market SaaS company that is now the leading provider of cloud-based solutions for the field service and last mile logistics industries. Sullens grew employee count from 38 to almost 300 and increased revenue by 800% while maintaining double-digit EBITDA margins, creating an award-winning culture and building a world class SaaS leadership team.

During his tenure, the company was a seven-time winner of NJ Best Places to Work, named an Inc. Best Place to Work and a five-time Inc. 5000 fastest growth award winner among other awards. Sullens was also named 2016 EY Entrepreneur of the Year in NJ for Software Services and won a Stevie award for People Focused CEO of the Year in 2017. He has a B.S. in Mechanical Engineering from Virginia Tech and an M.B.A. with Honors in Finance, Strategy and Entrepreneurship from the University of Chicago Booth School of Business.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => chris-sullens
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-08 14:24:07
            [post_modified_gmt] => 2019-03-08 14:24:07
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=51
            [menu_order] => 8
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [8] => WP_Post Object
        (
            [ID] => 57
            [post_author] => 1
            [post_date] => 2019-03-13 20:10:56
            [post_date_gmt] => 2019-03-13 20:10:56
            [post_content] => 
            [post_title] => Merwan Mereby
            [post_excerpt] => Merwan Mereby is Panasonic Corporation of North America’s Vice President of Technology & Strategic Partnerships. Mr. Mereby has more than twenty years of experience within Panasonic, developing and deploying strategies to create new business opportunities, technology and business innovation, to contribute to revenue growth, expand market footprint and increase profitability. 
	
Mr. Mereby has led the company’s efforts in acquiring new technologies such as Artificial Intelligence, Machine Learning, Over the top content distribution and targeted advertising platform, he also led the global incubation, expansion and innovation of connected products, identifying and implementing strategies to enable development of cloud-based compelling applications, services and solutions. All of these efforts contributed to Panasonic’s transformation and innovation.

Additionally, Mr. Mereby has led the Software and Analytics Solutions Group in North America to help Panasonic transform to a total solutions business and to build an IoT platform and predictive analytics solution.

In 2014 Mr. Mereby took on the leadership of the Smart TV Alliance, accepting the role of President. The Smart TV Alliance’s mission is to create a large and productive ecosystem for application development, enabling developers to write applications once for many different platforms and providing consumers with a rich source of content and services.

Mr. Mereby is also a member of the Board of Directors of Arimo LLC, a provider of Artificial Intelligence and Machine learning solutions and he is also a Board of Directors of Xumo LLC, a provider of innovative solution for over the top content and targeted advertising for connected devices.

Mr. Mereby earned a Bachelor of Science in Business Administration from the University of Louisiana.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => merwan-mereby
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-13 20:10:56
            [post_modified_gmt] => 2019-03-13 20:10:56
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=57
            [menu_order] => 9
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [9] => WP_Post Object
        (
            [ID] => 48
            [post_author] => 1
            [post_date] => 2019-03-06 19:16:17
            [post_date_gmt] => 2019-03-06 19:16:17
            [post_content] => 
            [post_title] => Tiffany McLaud
            [post_excerpt] => Tiffany McLaud is the Head of the Consumer Health Accelerator for Bayer Consumer Healthcare.  The Consumer Health Accelerator is a dedicated, cross-functional unit whose purpose is to gather and interpret early market signals to identify potential emerging trends, brands, capabilities and business models that have the potential to generate growth for Bayer Consumer Health US.  Once identified, the team then activates against those trends and quickly executes to realize the growth.

She joined Bayer in April 2017 as Vice President of Sales Strategy & Operations, where she was responsible for leading an integrated team that spans Sales Strategy, Shopper Marketing, Sales Planning & Effectiveness, and Sales Operations. 
  
Prior to Bayer, Tiffany served as Vice President of Marketing for CB Fleet Laboratories where she implemented strategic cross-functional teams for each category, successfully strengthening brand pipelines and achieving brand productivity targets. Previously, she oversaw the U.S. Healthcare portfolio for Reckitt Benckiser (RB) and was directly responsible for driving substantial category and brand growth across the RB Healthcare portfolio. She has also held various global and U.S. leadership roles at Pfizer Consumer Healthcare and Wyeth Consumer Healthcare.

Tiffany has a Masters in Corporate & Organizational Communications from Fairleigh Dickinson University and a B.A in Political Science from Colgate University.  She lives in Mendham, New Jersey with her husband, Steve, her three sons, twins Jack and Collyer, and Teddy, as well as their dog, Doc. 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => tiffany-mclaud
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-06 19:18:00
            [post_modified_gmt] => 2019-03-06 19:18:00
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=48
            [menu_order] => 10
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [10] => WP_Post Object
        (
            [ID] => 59
            [post_author] => 1
            [post_date] => 2019-03-13 20:19:23
            [post_date_gmt] => 2019-03-13 20:19:23
            [post_content] => 
            [post_title] => Steve LeVine
            [post_excerpt] => Steve LeVine is the future editor at Axios. Prior to Axios, LeVine was Washington Correspondent for Quartz, the mobile-first startup launched in 2012 by Atlantic Media. Steve is also a Future Tense Fellow at the New America Foundation and an adjunct professor at Georgetown University, where he teaches energy security in the graduate-level Security Studies Program. Previously, Steve was a foreign correspondent for 18 years in the former Soviet Union, Pakistan and the Philippines, running a bureau for The Wall Street Journal, and before that writing for The New York Times, the Financial Times and Newsweek. He is also an author of three books.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => steve-levine
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-13 20:21:18
            [post_modified_gmt] => 2019-03-13 20:21:18
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=59
            [menu_order] => 11
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [11] => WP_Post Object
        (
            [ID] => 61
            [post_author] => 1
            [post_date] => 2019-03-18 15:06:15
            [post_date_gmt] => 2019-03-18 15:06:15
            [post_content] => 
            [post_title] => Anastassia Loukina
            [post_excerpt] => Anastassia Loukina is a research scientist in the Research and Development division at Educational Testing Service (ETS) in Princeton NJ.  ETS develops, administers and scores more than 50 million tests annually in more than 180 countries at more than 9,000 locations worldwide. The NLP & Speech group at ETS develops technology for automated scoring of open-ended items, classroom support tools for teachers, and tools that can aid in the test development process. Since joining ETS, Anastassia has led the research to improve the validity, reliability and fairness of speech-based educational application and made key contribution to successful launch of several automated scoring system. She published more than 40 papers and book chapters, holds several patents and frequently attends international conferences and workshops. She is member of several professional organizations and a co-chair for the Industry Track of 2019 Annual Conference of the North American Chapter of the Association for Computational Linguistics. Before joining ETS, Anastassia worked at the Oxford University Phonetics Laboratory where she conducted research and taught graduate and undergraduate courses in linguistics and phonetics. She holds MPhil and DPhil from the University of Oxford.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => anastassia-loukina
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-18 15:06:15
            [post_modified_gmt] => 2019-03-18 15:06:15
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=61
            [menu_order] => 12
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [12] => WP_Post Object
        (
            [ID] => 71
            [post_author] => 1
            [post_date] => 2019-03-25 15:23:17
            [post_date_gmt] => 2019-03-25 15:23:17
            [post_content] => 
            [post_title] => Bob Zambon
            [post_excerpt] => Dr. Zambon is the Director, Real World Innovation, in Janssen Scientific Affairs at Janssen Pharmaceuticals.  In his role, Dr. Zambon leads and supports strategic innovation initiatives for Janssen Scientific Affairs focused on the usage of innovative technologies, analytics, data, and partnerships to accelerate and advance real world research and initiatives across all of Janssen’s therapeutic areas.  
 
Dr. Zambon has close to twenty years of experience in the life sciences industry with experience in strategy development, program management, clinical research, product development, sales force training, client management, regulatory affairs, analytics, and market research.  He’s led and supported research programs in the areas of cardiology, orthopedics, immunology, infectious disease, and medical countermeasures.
 
Dr. Zambon received his Ph.D. in Molecular & Cell Biology at the University of Maryland and his B.S. in Biotechnology at Rutgers University.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => bob-zambon
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-25 15:23:17
            [post_modified_gmt] => 2019-03-25 15:23:17
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=71
            [menu_order] => 13
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [13] => WP_Post Object
        (
            [ID] => 73
            [post_author] => 1
            [post_date] => 2019-03-25 15:29:46
            [post_date_gmt] => 2019-03-25 15:29:46
            [post_content] => 
            [post_title] => Gary Rosenblum
            [post_excerpt] => Gary Rosenblum has been President of Oticon, Inc. since October of 2016.  Gary is responsible for driving forward Oticon’s leadership in innovation, product quality and customer support. He brings a rich understanding of how customers and consumers are adapting to a changing healthcare environment.  Prior to Oticon, Gary ran several medical device and consumer healthcare businesses for Fortune 500 companies including Johnson & Johnson, Abbott Labs, and Pfizer.  Gary earned his MBA from Cornell University and his BA in Psychology and History from Washington University in St. Louis.   
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => gary-rosenblum
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-03-25 15:29:46
            [post_modified_gmt] => 2019-03-25 15:29:46
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=73
            [menu_order] => 14
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [14] => WP_Post Object
        (
            [ID] => 76
            [post_author] => 1
            [post_date] => 2019-03-26 14:55:46
            [post_date_gmt] => 2019-03-26 14:55:46
            [post_content] => 
            [post_title] => Dan Tinkoff
            [post_excerpt] => Dan is the global leader of McKinsey’s Data & Analytics Practice for pharmaceuticals and life
sciences companies. He leverages expertise in data analytics and deep industry knowledge to advise 
life sciences business leaders and Chief Digital/ Analytics Officers on their digital & analytics 
strategies and operating models. He also works extensively with digital & analytics organizations 
on how they transform and innovate their capabilities for today’s dynamic healthcare and technology 
landscape. Dan has 13 years of healthcare consulting experience, including extensive experience 
working with life sciences companies on strategy and business transformation.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => dan-tinkoff
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-04 19:51:42
            [post_modified_gmt] => 2019-04-04 19:51:42
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=76
            [menu_order] => 15
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [15] => WP_Post Object
        (
            [ID] => 85
            [post_author] => 1
            [post_date] => 2019-04-05 15:19:39
            [post_date_gmt] => 2019-04-05 15:19:39
            [post_content] => 
            [post_title] => Judy Comitto
            [post_excerpt] => 
Judy Comitto is Vice President IT and CIO at Trinitas Regional Medical Center a full-service healthcare facility serving Union County New Jersey.  Operating on two major campuses, Trinitas Regional Medical Center has 531 beds, including a 120-bed long-term care center. Trinitas Regional Medical Center is proud to offer state-of-the-art medicine backed by compassion and competence.  Responsibilities include strategic planning, systems and programming, user training and support, security and business recovery and telecommunications.
Ms. Comitto earned a bachelor’s degree from Hunter College in NYC as well as a Master of Public Administration with a concentration in Healthcare from LIU and has spent 30+ years in healthcare. In addition to her responsibilities at TRMC she is also a Vice Chair of Jersey Health Connect (major HIO in NJ), member of NJ HIMSS and a Chime member.    

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => judy-comitto
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-05 15:19:39
            [post_modified_gmt] => 2019-04-05 15:19:39
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=85
            [menu_order] => 16
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [16] => WP_Post Object
        (
            [ID] => 90
            [post_author] => 1
            [post_date] => 2019-04-09 14:22:16
            [post_date_gmt] => 2019-04-09 14:22:16
            [post_content] => 
            [post_title] => Eamon Gallagher
            [post_excerpt] => Eamon Gallagher works with several entrepreneurship and startup initiatives in and around Philadelphia, primarily with commercialization programs at the University City Science Center. As Program Director at ic@3401, Philadelphia’s largest community of funded start-ups, he works with startups to speed their development from teams of 2 with an idea to teams of 8 with a company. He is an attorney and serves as Director of Drexel Law School’s Entrepreneurial Law Clinic.

Eamon’s first career was in corporate recruiting. He earned a J.D. from Drexel Law with a concentration in Business and Entrepreneurship Law. He also holds a B.S. in Public Policy and a B.A. in Philosophy from the University of Rhode Island.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => eamon-gallagher
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-09 14:22:16
            [post_modified_gmt] => 2019-04-09 14:22:16
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=90
            [menu_order] => 17
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [17] => WP_Post Object
        (
            [ID] => 92
            [post_author] => 1
            [post_date] => 2019-04-09 15:34:06
            [post_date_gmt] => 2019-04-09 15:34:06
            [post_content] => 
            [post_title] => Jim Gunton
            [post_excerpt] => Jim Gunton, Managing Partner, of Tech Council Ventures has invested in privately-held growth technology companies for more than 20 years. Before co-founding in 2001 the $80 million NJTC Venture Fund, Jim was a partner at Edison Venture Fund and a manager at Oracle Corporation in the Silicon Valley. He served formerly as a Governor of the National Association of Small Business Investment Companies (NASBIC).

Jim earned a BS from Stanford University and an MBA with distinction from Duke University. He has served on the board of numerous private and public companies including Achieve3000, Amber Road (NYSE: AMBR), CytoSorbents (NASDAQ: CTSO), InstaMed, IntegriChain and CareGain.

Tech Council Ventures is a venture fund investing in early and expansion stage companies across all industries in the Mid-Atlantic region.  The fund invests $500K to $2M initially and provides additional support throughout the growth of the business.  Tech Council Ventures’ principals all have 20+ years investing and building promising, rapid growth companies.  The fund is affiliated with one of the largest and most active technology councils in the US, the NJ Tech Council, providing for its portfolio investments an unmatched network of customer, key team recruits, business partner and service provider connections.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => jim-gunton
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-09 15:34:06
            [post_modified_gmt] => 2019-04-09 15:34:06
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=92
            [menu_order] => 18
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [18] => WP_Post Object
        (
            [ID] => 96
            [post_author] => 1
            [post_date] => 2019-04-15 16:19:46
            [post_date_gmt] => 2019-04-15 16:19:46
            [post_content] => 
            [post_title] => David Sorin
            [post_excerpt] => Dave Sorin is an office managing partner of McCarter & English and Co-Chair of the Venture Capital & Emerging Growth Companies practice. His national practice focuses primarily on privately- and publicly-owned startup, early stage, emerging growth, and middle market technology, tech-enabled and life science enterprises, as well as the investors, executives, and boards of directors who support and lead them. Dave has a long track record of successful representation of growth companies, having been repeatedly recognized by well-known periodicals for a unique combination of legal acumen and sound business judgment. He also brings to bear his broad range of knowledge and experience in counseling enterprises and investors in diverse emerging growth markets, technology industries (including software, artificial and augmented intelligence, VR/AR, information technology, e-commerce, cybersecurity and communications), and life sciences. Dave is a thought leader in the emerging areas of blockchain, smart contracts and digital currencies—not only talking the talk by participating in speaking engagements and authoring articles, but walking the walk by representing venture capital investors and companies employing such technologies, and working on matters in connection with utility and security tokens, SAFTs, and ICOs (including under Regulations D and A).
One industry-leading publication has recognized Dave as one of New Jersey’s top 100 business people, categorizing him within an “elite group” of executives who “are the voices of their industries.” He was later identified by another industry publication as one of the region’s “top deal makers.” Chambers USA, an international guide to lawyers and law firms, called Dave the State’s top corporate lawyer, and, in 2017, a national leader in the representation of startup and emerging growth companies. SmartCEO Magazine named McCarter the large law firm of the year in the tech and tech-enabled industry sector and named Dave the leading lawyer in the industry. In addition, Dave Sorin received the Star Influencer Award at SmartCEO’s Centers of Influence Event. 
Dave co-founded the law firm of SorinRand in 2009, was Managing Partner of the New Jersey and New York law offices of Buchanan Ingersoll Professional Corporation and of the Princeton office of Hale & Dorr LLP (now WilmerHale LLP), as well as a corporate practice area Vice-Chair. In addition, he serves as an adjunct professor, teaching a course on high-growth corporate transactions at the Cornell Law School Technology Law LLM Program. Previously, Dave served as a Clinical Associate Professor of Law at Drexel University, teaching Entrepreneurial Law, Legal Issues for Start-Ups, Venture Capital and Corporate Governance. He also served as an Adjunct Professor of Law at Seton Hall University School of Law, teaching Accounting for Lawyers and Mergers & Acquisitions. He began his legal career at Davis Polk & Wardwell.
The realities of the 21st century economy, dramatic advances in technology and rigorous analysis of their effects on the business and legal marketplace convinced Dave that service to startup, early stage, emerging growth and middle market enterprises is largely incompatible with the cost infrastructure, high leverage, and fee schedules generally associated with today’s law firm model. He and his partners founded SorinRand to meet the new business realities head-on, reinventing law firm practice to help clients achieve their goals, sensibly. Together, they joined McCarter & English to leverage McCarter’s geographical scale, size, and breadth of services to provide clients the many disciplines they require throughout their business lifecycles, while retaining the unique delivery model and value proposition offered by SorinRand.
Dave, who is a frequent speaker, panelist, and author on issues of interest to the emerging growth and middle market sectors, also is a Certified Public Accountant.
In 2016, he co-founded entreprenYOURS, Inc., a new accelerator program for startup tech and tech-enabled companies in New York and New Jersey, characterized by a unique system of cross-equity ownership designed to foster collaboration and community among the accelerator’s portfolio companies. In addition, he helped to co-found a new venture capital fund focused on investing in early-stage and emerging growth companies in New Jersey and the surrounding region that have demonstrated early traction in consumer-facing technologies and Internet-of-Things (IoT) verticals, among other tech and tech-enabled industry sectors.
Professional Accomplishments:
•	Named a national leader in the representation of startup and emerging growth companies by Chambers, 2017-2018;
•	Recognized by New Jersey Law Journal as a Distinguished Leader of the Bar, 2017;
•	Received the Star Influencer Award by SmartCEO, 2016; 
•	Named Leading Lawyer in the Tech and Tech-Enabled Industry Sector by SmartCEO;
•	Named a Super Lawyer in both Metro NY and NJ in Securities & Corporate Finance, Business/Corporate, Mergers & Acquisitions in 2012-2018; 
•	Inducted into the New Jersey Technology Council Hall of Fame, 2011; 
•	Recipient of the NJTC John H. Martinson Technology Supporter Award;
•	Recipient of the Legend of Technology Award from NJTC.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => david-sorin
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-15 16:19:46
            [post_modified_gmt] => 2019-04-15 16:19:46
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=96
            [menu_order] => 19
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [19] => WP_Post Object
        (
            [ID] => 112
            [post_author] => 1
            [post_date] => 2019-04-26 14:35:03
            [post_date_gmt] => 2019-04-26 14:35:03
            [post_content] => 
            [post_title] => Jack Quigley
            [post_excerpt] => Jack Quigley is the Chief Architect at Horizon Blue Cross Blue Shield of New Jersey.  Jack is accountable for all disciplines across Horizon’s IT Architecture, which includes Platform and Technical Architecture, Data Architecture, Solutions Architecture and Architecture Governance.  He joined Horizon in 2016 as Director of Data Architecture, prior to assuming his current role in 2018. Jack’s broad experience includes development and leadership roles in telecommunications, high tech, health plans and PBM.  He holds a bachelor degree in computer science from Rutgers University, New Brunswick, and a master’s degree from Stevens Institute of Technology, Hoboken.  Jack resides in New Jersey, with his wife Maureen and their four sons.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => jack-quigley
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-26 14:35:03
            [post_modified_gmt] => 2019-04-26 14:35:03
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=112
            [menu_order] => 20
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [20] => WP_Post Object
        (
            [ID] => 119
            [post_author] => 1
            [post_date] => 2019-04-29 14:43:43
            [post_date_gmt] => 2019-04-29 14:43:43
            [post_content] => 
            [post_title] => Colleen Riley
            [post_excerpt] => Dr. Colleen Riley is the Vice President, Science and Technology for the Joint Replacement Division of Stryker Orthopaedics where she is responsible for leading the Advanced Technology and Regulatory Affairs groups.

Prior to joining Stryker in 2014, Colleen held a rich career in a number of senior leadership positions in Research and Development, Medical, Clinical and Regulatory Affairs. She played integral roles in leading teams in all stages of global product and technology development in medical devices, pharmaceuticals, and over the counter (OTC) products. She also brings progressive experience as a scientist, practicing clinician and educator. She has held faculty positions at Indiana University and served on numerous boards.
In 2007, she was selected as one of the top “20 Most Influential Women in the Optical Industry”.  Colleen is a Fellow and a Contact Lens Diplomate in the Section on Cornea, Contact Lenses and Refractive Technologies of the American Academy of Optometry. Colleen attended Indiana University where she received her Doctor of Optometry, Master of Science in Physiological Optics and a Bachelor’s degree in Chemistry.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => colleen-riley
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-29 14:43:43
            [post_modified_gmt] => 2019-04-29 14:43:43
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=119
            [menu_order] => 21
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [21] => WP_Post Object
        (
            [ID] => 117
            [post_author] => 1
            [post_date] => 2019-04-29 13:54:53
            [post_date_gmt] => 2019-04-29 13:54:53
            [post_content] => 
            [post_title] => Dan Borok
            [post_excerpt] => Dan is a co-Founder and Managing Partner at Newark Venture Partners. He has been in the venture space since 2005, most recently as a Partner at Millennium Technology Value Partners. He was previously a business analyst at Google. 

Dan focuses on B2B tech, including themes such as healthcare, insurance, future of work and enterprise automation.

Dan has an MBA from Columbia Business School and a BA from University of Vermont.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => dan-borok
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-29 13:54:53
            [post_modified_gmt] => 2019-04-29 13:54:53
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=117
            [menu_order] => 22
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [22] => WP_Post Object
        (
            [ID] => 115
            [post_author] => 1
            [post_date] => 2019-04-26 18:09:15
            [post_date_gmt] => 2019-04-26 18:09:15
            [post_content] => 
            [post_title] => Sanjay Macwan
            [post_excerpt] => In his role as SVP, Enterprise Engineering and Networks, Sanjay Macwan leads Vonage's enterprise platform and engineering teams to drive innovation and new development in the Company's solutions for Enterprise customers.  
With more than 20 years of experience in technology leadership, strategy and execution, Sanjay has built and led highly successful technology innovation programs that have delivered transformation, operational efficiency and a sustained culture of innovation across multiple industries.
Prior to Vonage, Sanjay was the Senior Vice President and Chief Technology Officer at NBCUniversal focused on driving innovation across all lines of business. He helped the company deliver next- generation content experiences leveraging emerging technologies including virtual reality, augmented reality, ultra-high definition, IoT, machine learning and more across various platforms. 
Earlier in his career, Sanjay also led AT&T’s Technology Council in the Chief Technology Office where he was responsible for accelerating technology innovation for the company and its ecosystem. During many years at AT&T Labs, he also led large scale R&D in multimedia, mobility, information security and cloud. 
Sanjay is the founder of The Holmdel Idea Summit (THIS) – a STEAM program connecting talented high-school and college students, accomplished innovators and business leaders from our community. Vonage is a proud sponsor of this community initiative, which was held for the first time in 2017.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => sanjay-macwan
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-26 18:09:15
            [post_modified_gmt] => 2019-04-26 18:09:15
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=115
            [menu_order] => 23
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [23] => WP_Post Object
        (
            [ID] => 101
            [post_author] => 1
            [post_date] => 2019-04-17 14:26:30
            [post_date_gmt] => 2019-04-17 14:26:30
            [post_content] => 
            [post_title] => Tim Rollender
            [post_excerpt] => Timothy Rollender is a Senior Venture Officer in the EDA’s TLS division, where he is responsible for marketing the Edison Innovation Fund and technology-led state incentives to potential applicants, consultants, technology transfer offices and partnering organizations.
Tim joined the EDA after working as a Senior Analyst for asset management firm Hirtle, Callaghan & Co., where he led due diligence on alternative investment opportunities. He also worked as an Investment Analyst for the New Jersey Department of the Treasury, Division of Investment, and has extensive experience in private and public equity investing.
Tim earned an MBA from Temple University’s Fox School of Business and a BA in Economics and Philosophy from Drew University in Madison.


            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => tim-rollender
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-17 14:26:30
            [post_modified_gmt] => 2019-04-17 14:26:30
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=101
            [menu_order] => 24
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [24] => WP_Post Object
        (
            [ID] => 110
            [post_author] => 1
            [post_date] => 2019-04-25 12:00:23
            [post_date_gmt] => 2019-04-25 12:00:23
            [post_content] => 
            [post_title] => Ibrahim Mohamed
            [post_excerpt] => Ibrahim Mohamed is the Head of Enablement at Google Cloud. In this role, he works with the global strategic partnerships on competency and solutions development differentiated by Google Cloud AI, Data, Analytics and Infrastructure capabilities. Prior to Google, Ibrahim worked at Microsoft, VMware and LinkedIn in various software development, product management and solutions engineering leadership roles with Microsoft Azure, VMware Cloud Foundation and LinkedIn Platform as a Service.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => ibrahim-mohamed
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-25 12:00:23
            [post_modified_gmt] => 2019-04-25 12:00:23
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=110
            [menu_order] => 25
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [25] => WP_Post Object
        (
            [ID] => 103
            [post_author] => 1
            [post_date] => 2019-04-18 12:36:27
            [post_date_gmt] => 2019-04-18 12:36:27
            [post_content] => 
            [post_title] => Brian McLaughlin
            [post_excerpt] => Brian P. McLaughlin is Distinguished Professor of Philosophy and Cognitive Science and the Director of the Rutgers Center for Cognitive Science.  He works in the philosophy of mind and has written on robot ethics.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => brian-mclaughlin
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-18 16:21:01
            [post_modified_gmt] => 2019-04-18 16:21:01
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=103
            [menu_order] => 26
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [26] => WP_Post Object
        (
            [ID] => 98
            [post_author] => 1
            [post_date] => 2019-04-16 17:15:54
            [post_date_gmt] => 2019-04-16 17:15:54
            [post_content] => 
            [post_title] => Cathy Bennett
            [post_excerpt] => Cathleen D. Bennett, Esq., took the helm November 9, 2017, as president and CEO of the New Jersey Hospital Association, a nonprofit trade association representing New Jersey’s hospitals, health systems, behavioral healthcare systems, rehabilitation hospitals, psychiatric hospitals, assisted living, nursing homes and other healthcare providers that provides leadership on quality and patient safety, education and advocacy in both Washington, D.C. and in Trenton.
As CEO, Bennett oversees NJHA, the Health Research and Educational Trust of New Jersey, a not-for-profit affiliate that promotes continuing education, patient safety, quality improvement and research; and the for-profit Healthcare Business Solutions, which provides group purchasing and other business solutions for healthcare providers. She co-founded Q3HIP, LLC in 2018 with a focus on improving quality of care, patient safety and education and leveraging the collective capabilities of the Hospital Associations of New Jersey, Pennsylvania and Ohio. 
Prior to being selected as CEO of NJHA, Bennett served as New Jersey’s 20th Health Commissioner. 

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => cathy-bennett
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-04-16 17:15:54
            [post_modified_gmt] => 2019-04-16 17:15:54
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/futureforum19/?post_type=events_speakers&p=98
            [menu_order] => 27
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

)

Sponsors

Sponsors

Registration

  • MEMBER Conference Ticket (HealthTech + Innovation) Early Bird $75 by 4/5: $95
  • FUTURE MEMBER Conference Ticket (HealthTech + Innovation) Early Bird $195 by 4/5: $295
  • MEMBER Conference Tix + STEM Awards - Early Bird $95 by 4/5: $145
  • FUTURE MEMBER - Conference Tix + STEM Awards - Early Bird $295 by 4/5: $395
  • MEMBER - STEM Awards ONLY - Early Bird $45 by 4/5: $65
  • FUTURE MEMBER - STEM Awards ONLY - Early Bird $75 by 4/5: $100
  • Exhibitor - HealthTech: $1500.00
  • Exhibitor - Innovation Forecast: $1500.00
  • Students/Faculty: Free with Valid School Email/ID (HealthTech + Innovation Forecast ONLY): $0